Istituto Clinico Humanitas - U.O. di Oncologia Medica ed Ematologia

Rozzano

0 studies enrolling now · 3 studies all time

What they study most

Head and Neck Cancer, Non-Small Cell Lung Cancer, Solid Tumors

Studies at this site

• Avelumab Program Rollover Study — Running, not enrolling
• Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322) — Running, not enrolling
• Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) — Stopped early